Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Oncoimmunology|September 28, 2013
Neuroblastoma-related inflammation: May small doses of aspirin be suitable for small cancer patients?Lena-Maria Carlson, Per Kogner
Cancers|February 24, 2024
Recent Advances in Neuroblastoma ResearchJohn Inge Johnsen, Per Kogner
Experimental Cell Research|March 10, 2010
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?Helena Gleissman, John Inge Johnsen, Per Kogner
International Journal of Oncology|September 30, 2010
Suppression of RIZ in biologically unfavourable neuroblastomasJanos Geli, Nimrod Kiss, Per Kogner, et al.
Molecular Cancer|June 15, 2012
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaAnna Djos, Tommy Martinsson, Per Kogner, et al.
Cancer Cell International|March 17, 2021
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastomaSimon Keane, Tommy Martinsson, Per Kogner, et al.
Journal of Molecular Signaling|April 20, 2013
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomasSusanne Fransson, Per Kogner, Tommy Martinsson, et al.
BMC Medical Genetics|October 4, 2013
Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 geneAnna Djos, Susanne Fransson, Per Kogner, et al.
The Biochemical Journal|November 8, 2008
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumoursHelena Carén, Frida Abel, Per Kogner, et al.
Advances in Experimental Medicine and Biology|September 29, 2019
Targeting the COX/mPGES-1/PGE<sub>2</sub> Pathway in NeuroblastomaKarin Larsson, Anna Kock, Per Kogner, et al.
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Oncoimmunology|September 28, 2013
Neuroblastoma-related inflammation: May small doses of aspirin be suitable for small cancer patients?Lena-Maria Carlson, Per Kogner
Cancers|February 24, 2024
Recent Advances in Neuroblastoma ResearchJohn Inge Johnsen, Per Kogner
Experimental Cell Research|March 10, 2010
Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?Helena Gleissman, John Inge Johnsen, Per Kogner
International Journal of Oncology|September 30, 2010
Suppression of RIZ in biologically unfavourable neuroblastomasJanos Geli, Nimrod Kiss, Per Kogner, et al.
Molecular Cancer|June 15, 2012
The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaAnna Djos, Tommy Martinsson, Per Kogner, et al.
Cancer Cell International|March 17, 2021
The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastomaSimon Keane, Tommy Martinsson, Per Kogner, et al.
Journal of Molecular Signaling|April 20, 2013
Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomasSusanne Fransson, Per Kogner, Tommy Martinsson, et al.
BMC Medical Genetics|October 4, 2013
Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 geneAnna Djos, Susanne Fransson, Per Kogner, et al.
The Biochemical Journal|November 8, 2008
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumoursHelena Carén, Frida Abel, Per Kogner, et al.
Advances in Experimental Medicine and Biology|September 29, 2019
Targeting the COX/mPGES-1/PGE<sub>2</sub> Pathway in NeuroblastomaKarin Larsson, Anna Kock, Per Kogner, et al.
Pageof 17